Trial intelligence / Profile preview

Postoperative pain and intracanal bacterial reduction after two-visit root canal treatment using antibiotic paste versus calcium hydroxide

PACTR201403000667409Not yet recruiting

Sponsor
sherif el shershaby
Start
Sep 2014
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of calcium hydroxide in pulpal necrosis (2 arms), sponsored by sherif el shershaby. Primary endpoint: postoperative pain. Planned start Sep 2014; status: not yet recruiting.

02

Drugs

calcium hydroxide
03

Conditions

pulpal necrosis

Beyond the preview

Go deeper on PACTR201403000667409.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201403000667409.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call